----

----

**UNITED      STATES**

**SECURITIES      AND EXCHANGE COMMISSION**

**FORM      10-QSB**

**January      31, 2007**

**MED-TECH      SOLUTIONS, INC.**

| NEVADA                                                          | 98-0442163                                       |
|-----------------------------------------------------------------|--------------------------------------------------|
| (State                or other jurisdiction of incorporation or | (IRS                Employer Identification No.) |
| organization)                                                   |                                             |

----

**TABLE      OF CONTENTS**

| PART                I. FINANCIAL INFORMATION   |                                                                                                                                                                                                                                                                       |
|-----------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                |                                                                                                                                                                                                                                                                       | **Page** |
|                     ITEM 1.     | Financial                Statements (unaudited)                                                                                                                                                                                                                            |   |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Condensed                  Balance Sheets at January 31, 2007 and October 31,                  2006                                                                                                                                                                        | 4 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Condensed                  Statements of Operations for the three months ended January                  31,                  2007 and 2006 and                  for the period from May 28, 2004 (date of inception) to January                  31,                  2007 | 5 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Condensed                  Statement of Cash Flows for the three months ended January                  31, 2007                  and 2006 and for the period from May 28, 2004 (date of inception)                  through                  January 31, 2007              | 6 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Condensed                Statements of Deficiency in Stockholders’ Equity for the period from May                28, 2004 (date of inception) through January 31, 2007                                                                                               |  7 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Notes                to unaudited                Condensed  Financial Statements                                                                                                                                                                            | 8 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 2      | Management’s                Discussion and Analysis or Plan of Operation                                                                                                                                                                                             | 17 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 3      | Controls                and Procedures                                                                                                                                                                                                                                     | 20 |
|                                                |                                                                                                                                                                                                                                                                       |   |
| PART                II. OTHER INFORMATION           |                                                                                                                                                                                                                                                                       |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 1      | Legal                Proceedings                                                                                                                                                                                                                                           | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 2.     | Unregistered                Sales of Equity Securities and Use of Proceeds                                                                                                                                                                                                 | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 3.     | Defaults                Upon Senior Securities                                                                                                                                                                                                                             | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 4.     | Submission                of Matters to a Vote of Security Holders.                                                                                                                                                                                                        | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 5.     | Other                Information                                                                                                                                                                                                                                           | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                     ITEM 6      | Exhibits                                                                                                                                                                                                                                                                   | 21 |
|                                                |                                                                                                                                                                                                                                                                       |   |
|                                                | Signatures                                                                                                                                                                                                                                                                 | 22 |

----

**PART      I - FINANCIAL INFORMATION**

**ITEM      1. FINANCIAL STATEMENTS.**

----

**MED-TECH        SOLUTIONS, INC.**

**(A        Development Stage Enterprise)**

**CONDENSED        BALANCE SHEET**

**(Expressed        in US Dollars)**

|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-----------------------------------|--------|--------|-----------------------------|--------|
|                                                                                                                                                                                                                                     |   |   | (Unaudited)                  |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   | January                  31  |   |   | October                  31 |   |
|                                                                                                                                                                                                                                |   |   | 2007                              |   |   | 2006                        |   |
| ASSETS                                                                                                                                                                                                                              |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| CURRENT                  ASSETS                                                                                                                                                                                                     |   |   |                              |   |   |                        |   |
| Cash                                                                                                                                                                                                                                |   | $      | 2,953                             |   | $      | 3,111                       |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Total                  assets                                                                                                                                                                                                       |   | $      | 2,953                             |   | $      | 3,111                       |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| LIABILITIES                  AND DEFICIENCY IN STOCKHOLDERS' EQUITY                                                                                                                                                                 |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| CURRENT                  LIABILITIES                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Accounts                  payable and accrued liabilities                                                                                                                                                                           |   | $      | 46,765                            |   | $      | 15,000                      |   |
| Due                  to director (Note 3)                                                                                                                                                                                           |   |   | 21,200                            |   |   | 21,200                      |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   | 67,965                            |   |   | 36,200                      |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Commitments                  and contingencies (Note 6)                                                                                                                                                                             |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| DEFICIENCY                  IN STOCKHOLDERS' EQUITY (Note 5)                                                                                                                                                                        |   |   |                              |   |   |                        |   |
| Preferred                  Shares;par value $0.001 per share;100,000,000 shares authorized,-0-                  and                  -0- issued and outstanding as of January 31, 2007 and October 31,                  2006        |   |   | -                                 |   |   | -                           |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Common                  stock ;par value $0.001 per share;500,000,000 shares authorized,                  and                  101,000,000 issued and outstanding as of January 31, 2007 and October                  31, 2006 |   |   | 101,000                           |   |   | 101,000                     |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Additional                  paid in capital                                                                                                                                                                                         |   |   | 4,000                             |   |   | 4,000                       |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Deficit                  accumulated during development stage                                                                                                                                                                       |   |   | (170,012                          | )      |   | (138,088                    | )      |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Total                  deficiency in stockholders' equity                                                                                                                                                                           |   |   | (65,012                           | )      |   | (33,088                     | )      |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
| Total                  liabilities and deficiency in stockholders' equity                                                                                                                                                           |   | $      | 2,953                             |   | $      | 3,112                       |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |
|                                                                                                                                                                                                                                |   |   |                              |   |   |                        |   |

----

**MED-TECH        SOLUTIONS, INC**

**(A        Development Stage Enterprise)**

**CONDENSED        STATEMENT OF OPERATIONS**

**(Expressed        in US Dollars)**

**(Unaudited)**

|                                                  |   |    | for                  the period       |   |   |                                        |   |   |                        |   |
|-------------------------------------------------------|--------|---------|--------------------------------------------|--------|--------|---------------------------------------------|--------|--------|-----------------------------|--------|
|                                                  |   |    | May                  28, 2004         |   |   |                                        |   |   |                        |   |
|                                                       |   |    | (date                  of inception)  |   |   |                                        |   |   |                        |   |
|                                                       |   |    | through                               |   |   | for                  the three months ended |   |
|                                                       |   |    | January                  31           |   |   | January                  31                 |   |   | January                  31 |   |
|                                                  |   |    | 2007                                       |   |   | 2007                                        |   |   | 2006                        |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| OPERATING                  EXPENSES                   |   | $  | 170,012                                    |   |   | 31,924                                      |   |   | 2,608                       |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| LOSS                  FROM OPERATIONS                 |   |    | (170,012                                   | )      |   | (31,924                                     | )      |   | (2,608                      | )      |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| INCOME                  TAXES                         |   |    | -                                          |   |   | -                                           |   |   | -                           |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| NET                  LOSS FOR THE PERIOD              |   | $       | (170,012                                   | )      | $      | (31,924                                     | )      | $      | (2,608                      | )      |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| BASIC                  AND DILUTED LOSS PER SHARE     |   |    |                                       |   | $      | (0.000                                      | )      | $      | (0.000                      | )      |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
| WEIGHTED                  AVERAGE NUMBER OF BASIC AND |   |    |                                       |   |   |                                        |   |   |                        |   |
| DILUTED                  COMMON SHARES OUTSTANDING    |   |    |                                       |   |   | 101,000,000                                 |   |   | 101,000,000                 |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |
|                                                  |   |    |                                       |   |   |                                        |   |   |                        |   |

----

**MED-TECH        SOLUTIONS, INC.**

**(A      Develoment Stage Enterprise)**

****CONDENSED      STATEMENT OF CASH FLOWS****

**(Expressed        in US Dollars)**

**(Unaudited)**

|                                                                  |   |   | for                the period       |   |   |                                      |   |   |                      |   |
|-----------------------------------------------------------------------|--------|--------|------------------------------------------|--------|--------|-------------------------------------------|--------|--------|---------------------------|--------|
|                                                                  |   |   | May                28, 2004         |   |   |                                      |   |   |                      |   |
|                                                                  |   |   | (date                of inception)  |   |   |                                      |   |   |                      |   |
|                                                                       |   |   | through                             |   |   | for                the three months ended |   |
|                                                                       |   |   | January                31           |   |   | January                31                 |   |   | January                31 |   |
|                                                                  |   |   | 2007                                     |   |   | 2007                                      |   |   | 2006                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| OPERATING                ACTIVITIES                                   |   |   |                                     |   |   |                                      |   |   |                      |   |
| Net                loss for the period                           |   | $      | (170,012                                 | )      | $      | (31,924                                   | )      | $      | (2,608                    | )      |
| Item                not affecting cash                           |   |   |                                     |   |   |                                      |   |   |                      |   |
|  Amortization                of license agreement                |   |   | 165                                      |   |   | -                                         |   |   | 41                        |   |
|  Write                off of license agreement                   |   |   | 8,065                                    |   |   | -                                         |   |   | -                         |   |
| Changes                in non-cash working capital items         |   |   |                                     |   |   |                                      |   |   |                      |   |
|  Accounts                payable and accrued liabilities         |   |   | 46,766                                   |   |   | 31,766                                    |   |   | (461                      | )      |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| Cash                used by operating activities                 |   |   | (115,016                                 | )      |   | (158                                      | )      |   | (3,028                    | )      |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| FINANCING                ACTIVITIES                                   |   |   |                                     |   |   |                                      |   |   |                      |   |
| Advance                from shareholders                         |   |   | 21,200                                   |   |   | -                                         |   |   | (3,200                    | )      |
| Issuance                of share capital                         |   |   | 105,000                                  |   |   | -                                         |   |   | -                         |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| Cash                provided by (used for) financing activities  |   |   | 126,200                                  |   |   | -                                         |   |   | (3,200                    | )      |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| INVESTING                ACTIVITIES                                   |   |   |                                     |   |   |                                      |   |   |                      |   |
| Acquisition                of license agreement                  |   |   | (8,231                                   | )      |   | -                                         |   |   | -                         |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| Cash                used by investing activities                 |   |   | (8,231                                   | )      |   | -                                         |   |   | -                         |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| CASH                INCREASE/(DECREASE)                               |   |   | 2,953                                    |   |   | (158                                      | )      |   | (6,228                    | )      |
| CASH,                BEGINNING OF PERIOD                              |   |   | -                                        |   |   | 3,111                                     |   |   | 26,553                    |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| CASH,                END OF PERIOD                                    |   | $      | 2,953                                    |   | $      | 2,953                                     |   | $      | 20,325                    |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |
| SUPPLEMENTAL                CASH FLOW INFORMATION:                    |   |   |                                     |   |   |                                      |   |   |                      |   |
| Interest                paid                                     |   | $      | -                                        |   | $      | -                                         |   | $      | -                         |   |
| Income                taxes paid                                 |   | $      | -                                        |   | $      | -                                         |   | $      | -                         |   |
|                                                                  |   |   |                                     |   |   |                                      |   |   |                      |   |

----

**MED-TECH        SOLUTIONS, INC.**

**(A      Development Stage Enterprise)**

**CONDENSED      STATEMENT OF DEFICIENCY IN STOCKHOLDERS' EQUITY**

**FOR      THE PERIOD FROM MAY 28, 2004 (DATE OF INCEPTION) TO JANUARY 31,      2007**

**(Expressed        in US Dollars)**

**(Unaudited)**

|                                                |   |   |                                 |   |   |                       |   |   |                        |   |   | Deficit                     |   |   |          |   |
|------------------------------------------------|--------|--------|--------------------------------------|--------|--------|----------------------------|--------|--------|-----------------------------|--------|--------|----------------------------------|--------|--------|---------------|--------|
|                                                |   |   |                                 |   |   |                       |   |   |                        |   |   | Accumulated                 |   |   | Total         |   |
|                                           |   |   | Common                  Shares  |   |   | Additional                 |   |   | During                  the |   |   | Deficiency                    in |   |
|                                                |   |   | Number                          |   |   |                       |   |   | Paid                  In    |   |   | Develoment                       |   |   | Stockholders' |   |
|                                           |   |   | of                  Shares      |   |   | Par                  Value |   |   | Capital                     |   |   | Stage                            |   |   | Equity        |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| May                  2004, issued common       |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| shares                  for cash $0.0001       |   |   | 50,000,000                           |   | $      | 50,000                     |   | $      | (45,000                     | )      | $      | -                                |   | $      | 5,000         |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| September                  2004, issued common |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| shares                  for cash @ $0.001      |   |   | 50,000,000                           |   |   | 50,000                     |   |   | -                           |   |   | -                                |   |   | 50,000        |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Net                  loss for the period ended |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| October                  31, 2004              |   |   | -                                    |   |   | -                          |   |   | -                           |   |   | (9,076                           | )      |   | (9,076        | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Balance,                  October 31, 2004     |   |   | 100,000,000                          |   |   | 100,000                    |   |   | (45,000                     | )      |   | (9,076                           | )      |   | 45,924        |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| November                  2004, issued common  |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| shares                  for cash @ $0.05       |   |   | 1,000,000                            |   |   | 1,000                      |   |   | 49,000                      |   |   | -                                |   |   | 50,000        |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Net                  loss for the year ended   |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| October                  31, 2005              |   |   | -                                    |   |   | -                          |   |   | -                           |   |   | (71,086                          | )      |   | (71,086       | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Balance,                  October 31, 2005     |   |   | 101,000,000                          |   |   | 101,000                    |   |   | 4,000                       |   |   | (80,162                          | )      |   | 24,838        |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Net                  loss for the year ended   |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| October                  31, 2006              |   |   | -                                    |   |   | -                          |   |   | -                           |   |   | (57,926                          | )      |   | (57,926       | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Balance,                  October 31, 2006     |   |   | 101,000,000                          |   |   | 101,000                    |   |   | 4,000                       |   |   | (138,088                         | )      |   | (33,088       | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Net                  loss for the period ended |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| January                  31, 2007              |   |   | -                                    |   |   | -                          |   |   | -                           |   |   | (31,924                          | )      |   | (31,924       | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
| Balance,                  January 31, 2007     |   |   | 101,000,000                          |   | $      | 101,000                    |   | $      | 4,000                       |   | $      | (170,012                         | )      | $      | (65,012       | )      |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |
|                                           |   |   |                                 |   |   |                       |   |   |                        |   |   |                             |   |   |          |   |

----

**Med-Tech          Solutions, Inc.**

**(A          Development Stage Enterprise)**

**Notes          to the Condensed          Financial Statements**

**(Expressed          in US Dollars)**

**(Unaudited)**

**January          31, 2007**

----

| **1.                       ** | **Nature                  of Operations** |
|------------------------------------------------------------------|-------------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

----

| **2.                       ** | **Significant                  Accounting Policies** |
|------------------------------------------------------------------|------------------------------------------------------|
| **a)  ** | **Development                  stage company** |
|--------------------|------------------------------------------------|
| **b)  ** | **Foreign                  currency translation** |
|--------------------|---------------------------------------------------|
| **c)  ** | **Basic                  and diluted loss per share** |
|--------------------|-------------------------------------------------------|
| **d)  ** | **Financial                  instruments** |
|--------------------|--------------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

**January          31, 2007**

----

| **2.** | **Significant                    Accounting Policies**                    (continued) |
|--------|---------------------------------------------------------------------------------------|

| **e)  ** | **Income                  taxes** |
|--------------------|-----------------------------------|
| **f)  ** | **Recent                  accounting pronouncements** |
|--------------------|-------------------------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

**January          31, 2007**

| **2.** | **Significant                    Accounting Policies**                    (continued) |
|--------|---------------------------------------------------------------------------------------|

|  | **f)** | **Recent                    accounting pronouncements**(continued) |
|--|--------|--------------------------------------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

**January          31, 2007**

----

| **2.** | **Significant                    Accounting Policies**                    (continued) |
|--------|---------------------------------------------------------------------------------------|

|  | **f)** | **Recent                    accounting pronouncements**(continued) |
|--|--------|--------------------------------------------------------------------|

----

**Med-Tech              Solutions, Inc.**

**(A              Development Stage Enterprise)**

**Notes              to the Condensed              Financial Statements**

**(Expressed              in US Dollars)**

**(Unaudited)**

**January          31, 2007**

| **2.** | **Significant                    Accounting Policies**                    (continued) |
|--------|---------------------------------------------------------------------------------------|

|  | **f)** | **Recent                    accounting pronouncements**(continued) |
|--|--------|--------------------------------------------------------------------|

SFAS            159            permits entities to choose to measure many financial instruments, and            certain            other items, at fair value. SFAS            159            applies to reporting periods beginning after November 15, 2007. The adoption            of            SFAS 159 is not expected to have a material impact on the Company’s financial            condition or results of operations.

|  | **g)** | **Cash                    and cash equivalents**  |
|--|--------|--------------------------------------------------------|

|  | **h)** | **Stock-Based                    Compensation** |
|--|--------|-------------------------------------------------|

*Share-Based          Payment*
*Accounting          for Stock Issued to Employees*

|  | **i)** | **Revenue                    Recognition** |
|--|--------|--------------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

**January          31, 2007**

----

| **2.** | **Significant                    Accounting Policies**                    (continued) |
|--------|---------------------------------------------------------------------------------------|

|  | **j)** | **Advertising                    Costs** |
|--|--------|------------------------------------------|

|  | **k)** | **Research                    and Development** |
|--|--------|-------------------------------------------------|

|  | **l)** | **Segment                    Information** |
|--|--------|--------------------------------------------|

|  | **m)** | **Liquidity** |
|--|--------|---------------|

| **3.                       ** | **Related                  Party Transactions** |
|------------------------------------------------------------------|-------------------------------------------------|

|   | **a)** | During                    fiscal 2004, the President and Sole Director of the Company paid                    expenses                    on behalf of the Company. This advance was repaid during fiscal                    2005.                    Since inception the President and Sole Director of the Company                    has                    invoiced the Company for rent in the amount of $5,000 ($3,800                    paid). The                    balance is non-interest bearing, unsecured and due on demand.                    During                    fiscal 2006, the President and Sole Director of the Company advanced                    an                    additional loan of $20,000, on the same                    terms. |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | **b)** | During                    fiscal 2004 the President and Sole Director of the Company purchased                    50,000,000 common shares from treasury for cash of                    $5,000. |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **4.                       ** | **License                  Agreement** |
|------------------------------------------------------------------|----------------------------------------|

----

**Med-Tech            Solutions, Inc.**

**(A            Development Stage Enterprise)**

**Notes            to the Condensed            Financial Statements**

**(Expressed            in US Dollars)**

**(Unaudited)**

**January          31, 2007**

----

| **4.** | **License                    Agreement**(continued) |
|--------|-----------------------------------------------------|

| **5.                       ** | **Share                  Capital** |
|------------------------------------------------------------------|------------------------------------|

|   | In                    May 2004, the Company issued 50,000,000 common shares at $0.0001                    per share                    for gross proceeds of $5,000. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | In                    September 2004, the Company issued 50,000,000 common shares at                    $0.001 per                    share for gross proceeds of                    $50,000. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | In                    November 2004, the Company issued 1,000,000 common shares at                    $0.05 per                    share for gross proceeds of                    $50,000. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **6.** | **Commitments                    and contingencies** |
|--------|------------------------------------------------------|

----

**ITEM      2. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF      OPERATION.**

**Cautionary      Statement Regarding Forward-Looking Statements**

**RISK      FACTORS**

**INTRODUCTION**

*Organizational      History*

  

**RECENT      DEVELOPMENTS**

*En      Fuels Heads of Agreement*

----

*4Rivers      Heads of Agreement*

**PLAN      OF OPERATION**

*The      following discussion and analysis summarizes our plan of operation for the      next      twelve months, our results of operation for the three months ended January      31,      2007 and changes in our financial condition from our fiscal year ended October      31, 2006. The following discussion should be read in conjunction with the      Management’s Plan of Operation included in our Annual Report on Form 10-KSB for      the year ended October 31, 2006.*

**Plan      of Operation**

*License      agreement with MDMI Technologies Inc.*

----

**Cash      Requirements**

| **MILESTONES                AND OBJECTIVES**                                                                                                                                                                                                                                                                                         | **Anticipated****Costs**              | **Target                Date****For                Completion** |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|-----------------------------------------------------------------|
| **PHASE                III - INTERNATIONAL MARKET ENTRY**Ø                Full product release to identified international markets in                Asia.Ø                Initial clinical evaluation.Ø                510(k) filed in the United States.Ø                Complete clinical trials as required. |  $20,000     |  April                2008             |
| **TOTAL**                                                                                                                                                                                                                                                                                                                            | **$20,000**                           | **12                Months**                                    |

| **Category**                         | **Planned                Expenditures Over The Next Twelve Months** |
|--------------------------------------|---------------------------------------------------------------------|
| Professional                Fees (1) |                   $80,000 (1)                             |
| Office                Expenses       | $5,000                                                              |
| Travel                Expenses (2)   | $5,000                                                              |
| **TOTAL**                            | $90,000                                                             |

|   | (1)    | Includes                legal and accounting expenses associated with this statement and                as a                result of our becoming a reporting issuer under the Exchange                Act. |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                         |
|   | (2)    | Includes                travel expenses relating to the negotiation of international distribution                and marketing agreements for our                product.                                    |

----

**RESULTS      OF OPERATIONS**

***For      the Three Months Ended January 31, 2007***

|                                                        |   | Three                Months ended January 31 |    |
|-------------------------------------------------------------|--------|----------------------------------------------|---------|
|                                                        |   |                                         |    |   |   | Percentage |   |
|                                                        |   |                                         |    |   |   | Increase                / |   |
|                                                        |   | 2007                                         |    | 2006 |   | (Decrease) |   |
| Revenue                                                     |   | $                                            | -       |   | $ | - |   |   | n/a |   |
| Expenses                                                    |   |                                         | (31,924 | ) |   | (2,608 | ) |   | 1,124.07 | % |
| Net                Income (Loss)                            |   |                                         | (31,924 | ) |   | (2,608 | ) |   | 1,124.07 | % |
| Loss                Per Share(fully                diluted) |   |                                         | 0.00    |   |   | 0.00 |   |   | 0.00 |   |

**Revenue**

**Expenses**

|                                             |   | Three                Months ended January 31 |         |
|--------------------------------------------------|--------|----------------------------------------------|--------------|
|                                             |   |                                         |         |   |   | Percentage |   |
|                                             |   | 2007                                         |         | 2006 |   | Inc.                / (Dec.) |   |
| Accounting                and Audit              |   | $                                            | -            |   | $ | 1,000 |   |   | (100 | )% |
| Amortization                of License Agreement |   |                                         | -            |   |   | 41 |   |   | (100 | )% |
| Bank                Charges and Interest         |   |                                         | 44           |   |   | 22 |   |   | 100 | % |
| Consulting                Fees                   |   |                                         | -            |   |   | 945 |   |   | (100 | )% |
| Filing                and transfer fees          |   |                                         | 1,843        |   |   | - |   |   | 100 | % |
| Legal                                            |   |                                         |  30,037 |   |   | - |   |   |  100 | % |
| Office                and Miscellaneous          |   |                                         | -            |   |   | - |   |   | n/a |   |
| Rent                                             |   |                                         | -            |   |   | - |   |   | n/a |   |
| Travel                and accommodation          |   |                                         | -            |   |   | 600 |   |   | (100 | )% |
| Write                off of license agreement    |   |                                         | -            |   |   | - |   |   | n/a |   |
| Total                Expenses                    |   | $                                            | 31,924       |   | $ | 2,608 |   |   |   |   |

**Net      Loss**

**LIQUIDITY      AND CAPITAL RESOURCES**

| Working                Capital           |   |                               |    |                                     |   |                                                 |   |
|------------------------------------------|--------|------------------------------------|---------|------------------------------------------|--------|------------------------------------------------------|--------|
|                                     |   | At                January 31, 2007 |    |  At                October 31, 2006 |   |  PercentageIncrease                / (Decrease) |   |
| Current                Assets            |   | $                                  | 2,953   |                                     | $      | 3,111                                                |   |   | (5.08 | )% |
| Current                Liabilities       |   |                               | 67,965  |                                     |   | 36,200                                               |   |   | 87.75 | % |
| Working                Capital (Deficit) |   | $                                  | (65,012 | )                                        | $      | (33,089                                              | )      |   | 96.48 | % |

----

| Cash                Flows                                     |   |                              |   |                              |   |
|---------------------------------------------------------------|--------|-----------------------------------|--------|-----------------------------------|--------|
|                                                          |   | Three                Months Ended |   | Three                Months Ended |   |
|                                                          |   | January                31, 2007   |   | January                31, 2006   |   |
| Cash                Flows from (used in) Operating Activities |   | $                                 | (158   | )                                 | $      | (3,028 | ) |
| Cash                Flows from (used in) Investing Activities |   |                              | --     |                              |   | -- |   |
| Cash                Flows from (used in) Financing Activities |   |                              | --     |                              |   | (3,200 | ) |
| Net                Decrease in Cash During Period             |   | $                                 | (158   | )                                 | $      | (6,228 | ) |

**Future      Financings**

**OFF-BALANCE      SHEET ARRANGEMENTS**

**CRITICAL      ACCOUNTING POLICIES**

*License      Agreement*

  

**ITEM      3. CONTROLS AND PROCEDURES.**

----

**ITEM      3A(T). CONTROLS AND PROCEDURES **

**PART      II - OTHER INFORMATION**

| **ITEM** **1.**                                                                                                  | **LEGAL                PROCEEDINGS.**                                                          |
|-----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------|
|                                                                                                                  |                                                                                           |
| None.                                                                                                                 |                                                                                           |
|                                                                                                                  |                                                                                           |
| **ITEM** **2.**                                                                                                  | **UNREGISTERED                SALES OF EQUITY SECURITIES AND USE OF                PROCEEDS.** |
|                                                                                                                  |                                                                                           |
| None.                                                                                                                 |                                                                                           |
|                                                                                                                  |                                                                                           |
| *Purchases                of Equity Securities by the Small Business Issuer and Affiliated                Purchasers* |                                                                                           |
|                                                                                                                  |                                                                                           |
| None.                                                                                                                 |                                                                                           |
|                                                                                                                  |                                                                                           |
| **ITEM** **3.**                                                                                                  | **DEFAULTS                UPON SENIOR SECURITIES.**                                            |
|                                                                                                                  |                                                                                           |
| None.                                                                                                                 |                                                                                           |
|                                                                                                                  |                                                                                           |
| **ITEM** **4.**                                                                                                  | **SUBMISSION                OF MATTERS TO A VOTE OF SECURITY                HOLDERS.**         |

**ITEM      5. OTHER INFORMATION.**

| **ITEM                6.** | **EXHIBITS.** |
|----------------------------|---------------|

| Exhibit                Number |                  Description of Exhibits                                                                                                                                                                 |
|-------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1                           |                  Articles of Incorporation. (1)                                                                                                                                                          |
| 3.2                           |                  Bylaws, as amended. (1)                                                                                                                                                                 |
| 4.1                           |                  Form of Share Certificate. (1)                                                                                                                                                          |
| 31.1                          |                  Certification of Chief Executive Officer and Chief Financial Officer                as                adopted pursuant to Section 302 of the Sarbanes-Oxley Act of                2002. |
| 32.1                          |                  Certification of Chief Executive Officer and Chief Financial Officer                as                adopted pursuant to Section 906 of the Sarbanes-Oxley Act of                2002. |

**Notes**

| (1) | Incorporated                by reference to the Company’s Registration Statement on Form SB-2 filed                with the SEC on January 28, 2005. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

**SIGNATURES**

|                                   |                                                                                                                                                                                                                                                                                    |                                    |
|----------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------|
|                                   | **MED-TECH                SOLUTIONS, INC.**                                                                                                                                                                                                                                             |
|                              |                                                                                                                                                                                                                                                                               |                               |
| Date: March              22, 2007 | By:                                                                                                                                                                                                                                                                           | /s/ *Mark              A. McLeary* |
|                                   | Mark                A. McLeary                                                                                                                                                                                                                                                          |
|                                   | Chief                Executive Officer, Chief Financial Officer, President,                  Secretary, Treasurer and Director (Principal                    Executive Officer, Principal Financial Officer                      and Principal Accounting                      Officer) |